When COVID-19 created an urgent need for vaccines that could be made quickly, safely and cost-effectively, traditional manufacturing approaches were not sufficient to meet the demand. Biopharmaceutical companies therefore shifted to novel biotechnology platform-based techniques that could be more quickly adapted to manufacture COVID-19 vaccines, and that were more robust, customizable and flexible than traditional approaches. An examination of this transition by a Penn State-led team concludes that such smart manufacturing techniques could in the future be applied to other viruses, potentially allowing vaccine development to keep pace with constantly evolving pathogens.
Engineering student credits global perspective for success
psu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psu.edu Daily Mail and Mail on Sunday newspapers.
Additive Manufacturing Needs Quality Control
inddist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inddist.com Daily Mail and Mail on Sunday newspapers.